Tenax Therapeutics (TENX) Enterprise Value Growth (3y) (2014 - 2026)
Tenax Therapeutics (TENX) Enterprise Value Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Tenax Therapeutics | 655.78 Mn | 655.78 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -101.97% |
| Dec 31, 2025 | -258.13% |
| Sep 30, 2025 | -196.65% |
| Jun 30, 2025 | -144.34% |
| Mar 31, 2025 | -238.68% |
| Dec 31, 2024 | -157.06% |
| Sep 30, 2024 | -127.46% |
| Jun 30, 2024 | -62.61% |
| Mar 31, 2024 | -46.01% |
| Dec 31, 2023 | -13.41% |
| Sep 30, 2023 | -8.56% |
| Jun 30, 2023 | -43.28% |
| Mar 31, 2023 | -43.71% |
| Dec 31, 2022 | 26.73% |
| Sep 30, 2022 | 18.87% |
| Jun 30, 2022 | 6.73% |
| Mar 31, 2022 | 35.77% |
| Dec 31, 2021 | 24.28% |
| Sep 30, 2021 | -19.82% |
| Jun 30, 2021 | 30.16% |